CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) was the recipient of a significant increase in short interest in May. As of May 29th, there was short interest totaling 1,000 shares, an increase of ∞ from the May 14th total of 0 shares. Based on an average daily trading volume, of 623 shares, the short-interest ratio is currently 1.6 days.
CanSino Biologics Stock Performance
CanSino Biologics stock opened at C$3.10 on Monday. CanSino Biologics has a 12-month low of C$3.00 and a 12-month high of C$6.99. The company has a 50-day moving average price of C$3.69 and a 200 day moving average price of C$4.14.
About CanSino Biologics
CanSino Biologics Inc is a China-based biopharmaceutical company focused on the research, development and commercialization of vaccine products. Headquartered in Tianjin, the company leverages an adenovirus vector platform to develop single-dose and recombinant vaccines targeting a range of infectious diseases. CanSino’s pipeline includes its authorized COVID-19 vaccine, Convidecia (Ad5-nCoV), as well as candidates for Ebola, influenza and other pathogens.
Since its founding in 2009, CanSino has built end-to-end capabilities spanning antigen discovery, process development and large-scale manufacturing.
Featured Stories
- Five stocks we like better than CanSino Biologics
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
